Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions

Area of Science:

• Neuroimmunology
• Proteomics
• Extracellular Matrix Biology

Background:

• Matrix metalloproteinases (MMPs) are enzymes degrading extracellular matrix (ECM).
• MMPs are implicated in central nervous system (CNS) diseases like multiple sclerosis (MS).
• Elevated MMP-19 mRNA in MS lesions suggests a role in pathogenesis.

Purpose of the Study:

• Investigate MMP-19 protein expression and cellular localization in MS lesions.
• Determine the cellular sources of MMP-19 in normal and MS-affected brain tissue.
• Elucidate the potential contribution of MMP-19 to MS pathology.

Main Methods:

• Immunohistochemistry on well-characterized MS lesion stages.
• Analysis of protein expression in normal control white matter.
• In vitro studies using primary human microglia and astrocyte cultures.

Main Results:

• MMP-19 constitutively expressed by microglia in normal white matter.
• Increased MMP-19 expression in microglia in (p)reactive MS lesions.
• Strong MMP-19 immunoreactivity in myelin-laden macrophages in active MS lesions; occasional astrocyte positivity.
• Weak MMP-19 staining in astrocytes in chronic inactive lesions.
• MMP-19 expressed by microglia, but not astrocytes, in vitro.

Conclusions:

• MMP-19 is primarily expressed by microglia and macrophages in the MS CNS.
• MMP-19 may contribute to MS pathology through ECM remodeling.
• Potential roles in influencing leucocyte infiltration, axonal regeneration, and astrogliosis.